Retrospective cohort study analyzes pneumonia burden from carbapenem-resistant and carbapenem-sensitive strains, highlighting significant mortality differences.
Key Points
CRAB pneumonia results in a significantly higher mortality rate of 53.8% compared to 12.5% for CSAB.
Patients with CRAB experience longer lengths of stay, averaging 17.92 days versus 11.00 days for CSAB.
The study identified respiratory failure, sepsis, and acute respiratory distress syndrome as more prevalent in CRAB patients.
The average hospitalization cost for CRAB was significantly higher at $6993 compared to $3264 for CSAB.